Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
138,764,349
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
30,122,030
-
Shares change
-
+9,533,083
-
Total reported value, excl. options
-
$221,392,091
-
Value change
-
+$70,394,875
-
Put/Call ratio
-
208%
-
Number of buys
-
54
-
Number of sells
-
26
-
Price
-
$7.35
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q3 2016
As of 30 Sep 2016 ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) had 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,122,030 shares of stock of the company.
Largest 10 holders included OppenheimerFunds, Inc., QVT Financial LP, BlackRock Fund Advisors, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., RA CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, and STATE STREET CORP.
This table shows 118 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.